Molecule intelOpportunity: StrongEssential

Mebendazole

75 brands · 52 companies · product forms

ATC: P02CA01 1 DRAP alert

Opportunity snapshot

Launch attractiveness
52
Market saturation
85
Price room
100
Regulatory risk
50
75
brands
52
companies
Rs 345.08
median price
55
price points
255x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 5%

Price room

Across observed sources and strengths
CheapestRs 8.34
MedianRs 345.08
Most expensiveRs 2,126.71
Spread255×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 255.00x across 55 trusted points (Rs 8.34-2126.71). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Mebendazole — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2024-04-29
Recall Alert; Drug Products: Mebzole 100mg/5mL Suspension and Bioris 1mg/ml Oral Solution

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(15) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

52 canonical companies and 75 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 255.00x across 55 trusted points (Rs 8.34-2126.71). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2024-04-29 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.